United Capital Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $978K | Buy |
|
|||||
|
2025
Q2 | $514K | Buy |
|
|||||
|
2025
Q1 | $414K | Buy |
|
|||||
|
2024
Q4 | $348K | Sell |
|
|||||
|
2024
Q3 | $431K | Buy |
|
|||||
|
2024
Q2 | $369K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $235K | Sell |
|
|||||
|
2021
Q1 | $210K | Sell |
|
|||||
|
2020
Q4 | $410K | Sell |
|
|||||
|
2020
Q3 | $5.2M | Buy |
|
|||||
|
2020
Q2 | $4.92M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $284K | Hold |
|
|||||
|
2016
Q2 | $231K | Sell |
|
|||||
|
2016
Q1 | $267K | Sell |
|
|||||
|
2015
Q4 | $400K | Hold |
|
|||||
|
2015
Q3 | $342K | Sell |
|
|||||
|
2015
Q2 | $520K | Hold |
|
|||||
|
2015
Q1 | $442K | Buy |
|
|||||
|
2014
Q4 | $347K | Hold |
|
|||||
|
2014
Q3 | $279K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $235K | Hold |
|
|||||
|
2013
Q4 | $225K | Hold |
|
|||||
|
2013
Q3 | $224K | Buy |
|